Advertisement

Topics

UCL research indicates use of diabetes drug in Parkinson’s disease

19:00 EDT 7 Aug 2017 | Net Resources International

University College London (UCL) has carried out a study that indicated the potential of a common diabetes drug called exenatide as a disease-modifying therapy for treating Parkinson’s disease.

Original Article: UCL research indicates use of diabetes drug in Parkinson’s disease

NEXT ARTICLE

More From BioPortfolio on "UCL research indicates use of diabetes drug in Parkinson’s disease"

Quick Search
Advertisement
 

Relevant Topics

Nephrology - kidney function
Nephrology is a specialty of medicine and pediatrics that concerns itself with the study of normal kidney function, kidney problems, the treatment of kidney problems and renal replacement therapy (dialysis and kidney transplantation). Systemic conditions...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Parkinson's Disease
Parkinson's is a progressive neurological condition, affecting one person in every 500, 95% of which are over 40. It is caused by degeneration of more than 70% of the substantia nigra, which depletes the dopamine (the neurotransmitter involved in pro...